Concerning malformation observed after the use of loratadin (trade name Clarinase® , Clarityn®) during pregnancy

Posted by Administrator on February 2nd, 2006 — in Clarityn News

The Swedish authorities suspect that the use of medicine containing loratadin early on in pregnancy increases the occurrence of congenital deformities.
In the Swedish birth register, 15 cases of the malformation hypospadi (the opening of the urethra on the underside of the penis) have been found among 2,780 children borne by mothers, who have taken loratadin […]

No Comments »

F.D.A. Reviews Nonprescription Claritin

Posted by Administrator on February 2nd, 2006 — in Clarityn News

Efforts by the Schering-Plough Corporation to introduce a nonprescription Claritin, its best-selling allergy drug, may be delayed while the Food and Drug Administration reviews reports of birth defects in babies born to Swedish women who took the drug, the agency said.
The European Agency for the Evaluation of Medicinal Products is investigating reports that Claritin […]

No Comments »